readthroughSign in
CompanyAVTXNasdaqWayne, PA

Avalo Therapeutics, Inc.

Avalo Therapeutics develops monoclonal antibodies targeting the IL-1β pathway for immune-mediated inflammatory diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 5Latest story